Company Profile
Suzhou Fushilai Pharmaceutical researches, develops, produces, and sells pharmaceutical intermediates, active pharmaceutical ingredients (APIs), and health care raw materials in China and globally. The company offers lipoic acid products comprising granular alpha lipoic acid, R-lipoic acid, r-lipoic acid tromethamine salt, and 6,8-dichlorooctanoic acid ethyl ester.
Its portfolio also includes L-carnosine, phosphatidylcholine products, which include glycerylphosphatidylcholine, and erelcoxib API, a nonsteroidal anti-inflammatory analgesic used to relieve the pain symptoms of osteoarthritis.
Its products are used in medicines, dietary supplements, and cosmetics applications, as well as research and experimental development and capital market activities. Founded in 2000, Suzhou Fushilai Pharmaceutical is based in Changshu, China.